Skip to content
Abierto

Vendor, Seattle, WA

Twinstrand Biosciences Inc.

UEI HPY9BJWV8X31, CAGE 7R5X5

1 award and $49,988 obligated between June 27, 2024 and February 10, 2026, 0% under full and open competition, against 1.0 offers on average where reported.

Sells to

Awarding agencies by dollars.

Food and Drug Administration$49,988

Industries

NAICS on the awards, by dollars.

Research and Development in Biotechnology (except Nanobiotechnology)NAICS 541714$49,988

How it wins

Awards by competition, set-aside and type.

Not Competed Under SAP1
Purchase Order1

Awards

Every award in the window, by dollars obligated.

ContractAwarding officeDescribed asObligated
75F40124P00263Purchase Order, June 27, 2024, Not Competed Under SAP, 1 offersFDA Office of Acq Grant SVCSFood and Drug AdministrationTwinstrand Duplex Sequencing Mutagenesis KitNAICS 541714, PSC 6640$49,988
Places of performance
Washington
Transactions
3 across 1 awards